Multidisciplinary Management of Multiple Sclerosis Symptoms
Overview
Affiliations
Background: Effective management of multisymptomatic chronic diseases such as multiple sclerosis (MS) requires a multimodal, interdisciplinary approach. At MS clinics, numerous healthcare specialties are coordinated to provide patients with quality clinical care for all aspects of their disease. Settings and resource availability may vary between countries. Four specific specialty services from different EU countries are examined in more detail.
Summary: The multidisciplinary neurorehabilitation team in Rennes, France, provides specialized consultations (e.g. spasticity, urodynamic unit, devices), inpatient and outpatient intensive rehabilitation programs and therapeutic education. Management approaches are based on a patient's level of impairment as assessed by the Expanded Disability Status Scale. In Girona, Spain, neuropsychologists perform assessments as part of the neurological protocol for all patients with MS. Depending on the level of impairment and patients' characteristics (e.g. working or not working), cognitive deficits may be treated at home or at a neurorehabilitation center. In Barcelona, Spain, neuro-ophthalmologists are involved in the differential diagnosis and follow-up care of MS patients with visual disturbances; particular attention is given to patients' vision-related quality of life. Pain specialists at the Marianne Strauß Klinik in Berg, Germany, have developed a system for classifying MS pain syndromes and differentiating MS-related pain from non MS-related pain. Chronic pain management involves numerous disciplines and requires active engagement by patients in developing treatment plans. Key Messages: MS affects several body systems and patients invariably require specialized interdisciplinary support. Insight into services provided by various specialties and their fit within multidisciplinary care models at MS centers may facilitate the design or refinement of care models in other locations.
Filippi M, Gallo P, Gasperini C, Marfia G, Avolio C, Bergamaschi R J Neurol. 2025; 272(1):96.
PMID: 39775071 PMC: 11706871. DOI: 10.1007/s00415-024-12749-8.
Sacco R, Riccitelli G, Disanto G, Bogousslavsky J, Cavelti A, Czell D J Clin Med. 2024; 13(10).
PMID: 38792448 PMC: 11122311. DOI: 10.3390/jcm13102907.
Hajebrahimi S, Zeynalzadeh M, Shafigh A, Mostafaei H, Balafar M, Naghdi N Urol Res Pract. 2023; 49(6):392-405.
PMID: 37971389 PMC: 10765193. DOI: 10.5152/tud.2023.23137.
De Mase A, Spina E, Servillo G, Barbato S, Leone G, Giordano F Neurol Sci. 2023; 45(4):1557-1563.
PMID: 37926747 DOI: 10.1007/s10072-023-07166-0.
Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study.
Smith K, Piehl F, Olsson T, Alfredsson L, Hillert J, Kockum I J Neurol Neurosurg Psychiatry. 2022; 94(5):337-348.
PMID: 36539267 PMC: 10176386. DOI: 10.1136/jnnp-2022-329886.